HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interaction between lymphokine activated killer cells generated in the presence of cisplatin/FK-565 and tumor cells: transmission electron microscopy analysis.

Abstract
Lymphokine activated killer (LAK) cells generated in the presence of cisplatin/FK-565 along with interleukin-2 (IL-2) showed enhanced binding to tumor cells as compared with LAK cells generated in the presence of IL-2 alone. The LAK cells showed a reorientation of cellular organelles in the presence of tumor cells. LAK-tumor conjugate pairs showed vesicle-like structures in the extracellular pockets. The number of vesicles in the extracellular pockets was found to be increased in the case of LAK cells generated in the presence of cisplatin/FK-565 along with IL-2. The closer interaction between the LAK cell-target cell and the large number of vesicles in the extracellular space of conjugate pairs may explain the increased lysis of target cells by LAK cells generated in the presence of cisplatin/FK-565 along with IL-2 as compared with IL-2 alone.
AuthorsS Basu, A Sodhi
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 3 Issue 2 Pg. 155-62 (Apr 1992) ISSN: 0959-4973 [Print] England
PMID1525394 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Interleukin-2
  • Oligopeptides
  • heptanoyl-gamma-D-glutamyl-L-meso-diaminopimelyl-D-alanine
  • Cisplatin
Topics
  • Antibiotics, Antineoplastic (pharmacology)
  • Burkitt Lymphoma (pathology, ultrastructure)
  • Cell Communication (physiology)
  • Cisplatin (pharmacology)
  • Drug Interactions
  • Humans
  • Interleukin-2 (pharmacology)
  • Killer Cells, Lymphokine-Activated (drug effects, physiology, ultrastructure)
  • Leukocytes, Mononuclear (drug effects, physiology)
  • Microscopy, Electron
  • Oligopeptides (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: